Status:
COMPLETED
SAR407899 Single-dose in Treatment of Mild to Moderate Erectile Dysfunction
Lead Sponsor:
Sanofi
Conditions:
Erectile Dysfunction
Eligibility:
MALE
18-60 years
Phase:
PHASE2
Brief Summary
The primary objective of this clinical trial is to study the ability of SAR407899 to increase the duration of penile erection in male patients with mild-moderate Erectile Dysfunction. The secondary o...
Eligibility Criteria
Inclusion
- male with mild to moderate erectile dysfunction for at least 6 months
- written informed consent
Exclusion
- diabetes mellitus
- orthostatic hypotension
- hypogonadal testosterone level
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00914277
Start Date
May 1 2009
End Date
October 1 2009
Last Update
May 2 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis Administrative Office
Paris, France